首页> 外文期刊>Bioorganic and medicinal chemistry >Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting
【24h】

Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting

机译:核糖体靶向抗生素作为致癌瘤生物发生的抑制剂:旧支架用于RNA靶向的新视角

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression at the post-transcriptional level. It is now well established that the overexpression of some miRNAs (oncogenic miRNAs) is responsible for initiation and progression of human cancers and the discovery of new molecules able to interfere with their production and/or function represents one of the most important challenges of current medicinal chemistry of RNA ligands. In this work, we studied the ability of 18 different antibiotics, known as prokaryotic ribosomal RNA, to bind to oncogenic miRNA precursors (stem-loop structured pre-miRNAs) in order to inhibit miRNAs production. In vitro inhibition, binding constants, thermodynamic parameters and binding sites were investigated and highlighted that aminoglycosides and tetracyclines represent interesting pre-miRNA ligands with the ability to inhibit Dicer processing. (C) 2015 Elsevier Ltd. All rights reserved.
机译:microRNA(miRNA)是非编码RNA,其调节在转录后水平的基因表达。 现在已经很好地确定了一些miRNA(肿瘤内miRNA)的过表达负责人类癌症的开始和进展,并且发现能够干扰其生产和/或功能的新分子代表当前药用的最重要挑战之一 RNA配体的化学。 在这项工作中,我们研究了18种不同抗生素,称为原核核糖体RNA的能力,结合致癌miRNA前体(茎环结构预先麦芽瘤),以抑制MiRNA生产。 研究了体外抑制,结合常数,热力学参数和结合位点,并突出显示氨基糖苷和四环素代表有趣的预先生预配体,具有抑制Dicer加工的能力。 (c)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号